1-196902602-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001201550.3(CFHR4):c.243G>A(p.Thr81=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00167 in 1,610,032 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0091 ( 64 hom., cov: 32)
Exomes 𝑓: 0.00090 ( 55 hom. )
Consequence
CFHR4
NM_001201550.3 synonymous
NM_001201550.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.907
Genes affected
CFHR4 (HGNC:16979): (complement factor H related 4) This gene is a member of the complement factor H (CFH) gene family, and encodes one of the 5 CFH-related (CFHR) proteins. These 5 genes are closely linked to the CFH gene on chromosome 1q31-q32. The CFHRs are secreted plasma proteins synthesized primarily by the hepatocytes, and composed of highly-related short consensus repeats (SCRs). This protein enhances the cofactor activity of CFH, and is involved in complement regulation. It can associate with lipoproteins and may play a role in lipid metabolism. Alternatively spliced transcript variants encoding different isoforms (varying in the number of SCRs) have been described for this gene. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-196902602-G-A is Benign according to our data. Variant chr1-196902602-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1336563.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-196902602-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.907 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00913 (1382/151328) while in subpopulation AFR AF= 0.0322 (1322/41008). AF 95% confidence interval is 0.0308. There are 64 homozygotes in gnomad4. There are 650 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 64 AD,AR,Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR4 | NM_001201550.3 | c.243G>A | p.Thr81= | synonymous_variant | 2/10 | ENST00000608469.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR4 | ENST00000608469.6 | c.243G>A | p.Thr81= | synonymous_variant | 2/10 | 1 | NM_001201550.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00909 AC: 1375AN: 151218Hom.: 64 Cov.: 32
GnomAD3 genomes
AF:
AC:
1375
AN:
151218
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00215 AC: 538AN: 249666Hom.: 32 AF XY: 0.00158 AC XY: 214AN XY: 135418
GnomAD3 exomes
AF:
AC:
538
AN:
249666
Hom.:
AF XY:
AC XY:
214
AN XY:
135418
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000899 AC: 1312AN: 1458704Hom.: 55 Cov.: 30 AF XY: 0.000760 AC XY: 552AN XY: 725906
GnomAD4 exome
AF:
AC:
1312
AN:
1458704
Hom.:
Cov.:
30
AF XY:
AC XY:
552
AN XY:
725906
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00913 AC: 1382AN: 151328Hom.: 64 Cov.: 32 AF XY: 0.00879 AC XY: 650AN XY: 73934
GnomAD4 genome
AF:
AC:
1382
AN:
151328
Hom.:
Cov.:
32
AF XY:
AC XY:
650
AN XY:
73934
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 14, 2019 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at